CRISPR Therapeutics (CRSP) CEO pay: $22.0M actually paid in FY2025
$CRSP · CRISPR Therapeutics AGData through FY2025 — latest proxy filed 2026-04-21, checked for new filings 2026-08-21. Every number links to its source.
5.6× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2020 | Same, peer group since FY2020 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $7.7M | $22.0M | $5.9M | $34.25 | $119.92 | -$581.6M |
| 2024 | $33.2M | $10.0M | $4.7M | $64.63 | $113.84 | -$366.3M |
| 2023 | $12.3M | $24.8M | $4.8M | $102.78 | $115.42 | -$153.6M |
| 2022 | $20.7M | $1.7M | $2.1M | $66.74 | $111.27 | -$650.2M |
| 2021 | $17.0M | -$27.4M | -$2.8M | $124.42 | $124.89 | $377.7M |
| 2020 | $9.1M | $76.9M | $22.3M | $251.39 | $125.69 | -$348.9M |
A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated
Frequently asked
How much did the CRSP CEO make in 2025?
$21,973,308 in Compensation Actually Paid (CAP) as CRISPR Therapeutics AG's CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2026-04-21.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on CRSP: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary